Gazmend Temaj

9PUBLICATIONS
37CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMedical devicesNeonatologyMedical biochemistry - inorganic elements and compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
RiboScreenTM Technology Delivers Small-Molecule Ribodrugs to Convert Ribosomal Proteins into Molecular Valves for Tailored Protein Production Levels in Rare and Prevalent Disease †.

|Nov 25, 2024
Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies.

Gazmend Temaj, Silvia Chichiarelli, Sarmistha Saha

|Aug 10, 2024
RiboScreenTM Technology Delivers a Ribosomal Target and a Small-Molecule Ligand for Ribosome Editing to Boost the Production Levels of Tropoelastin, the Monomeric Unit of Elastin.

Bjoern Wimmer, Jan Schernthaner, Genevieve Edobor

|May 24, 2023
Case Report: Identification of likely recurrent CEP290 mutation in a child with Joubert syndrome and cerebello-retinal-renal features.

Lidvana Spahiu, John A Sayer, Emir Behluli

|Mar 29, 2023
Recoding of Nonsense Mutation as a Pharmacological Strategy.

Gazmend Temaj, Pelin Telkoparan-Akillilar, Nexhibe Nuhii

|Mar 01, 2023
Mucopolysaccharidosis type III (subtype IIIB) diagnosis as a spectrum disorder: A case report from Kosovo.

Lidvana Spahiu, Emir Behluli, Rifat Hadziselimovic

Pageof 2

Frequent Collaborators

3 joint publications

Silvia Chichiarelli

3 joint publications

Rifat Hadziselimovic

3 joint publications

Luciano Saso

2 joint publications

Emir Behluli